<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04325191</url>
  </required_header>
  <id_info>
    <org_study_id>1534734</org_study_id>
    <nct_id>NCT04325191</nct_id>
  </id_info>
  <brief_title>Melatonin and Salt on Blood Vessel Function</brief_title>
  <official_title>Melatonin and Salt on Blood Vessel Function</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Delaware</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Delaware</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Increased dietary sodium causes increases in oxidative stress and damages blood vessels.
      Americans eat more than the recommended amount of sodium. Melatonin is a powerful endogenous
      antioxidant that has reduced oxidative stress levels in clinical and healthy populations.
      This study will investigate whether melatonin can attenuate the negative effects of sodium on
      blood vessels.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Americans consume on average double the recommended amount of sodium established by
      organizations such as the American Heart Association and the Dietary Guidelines for
      Americans. Excess dietary sodium damages the inside of our blood vessels in a process known
      as endothelial dysfunction. This reduces the ability of blood vessels to dilate as much. This
      type of dysfunction can lead to the development of cardiovascular disease. Animal and human
      studies have identified one potential mechanism linking high sodium consumption and
      endothelial dysfunction; that is oxidative stress. Furthermore, high dietary sodium
      consumption has been shown to increase blood pressure reactivity in animal studies. Melatonin
      is a powerful endogenous antioxidant that has reduced oxidative stress levels in clinical and
      healthy populations. Melatonin has been shown to attenuate sympathetic responses, but
      research is limited. Whether supplementation of melatonin can offset the deleterious effects
      of a high sodium diet is unknown. Thus, the purpose of this study is to investigate the
      effect of melatonin supplementation compared to a placebo on markers of oxidative stress and
      blood vessel function in healthy young adults that consume a 10-day high sodium diet. Our
      hypotheses are that: 1) melatonin will reduce oxidative stress levels and restore blood
      vessel function and 2) melatonin will reduce the sympathetic nerve response to high sodium
      consumption.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 12, 2020</start_date>
  <completion_date type="Anticipated">August 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>This is a randomized crossover design trial.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Participant will not know if they are receiving the melatonin or placebo pills.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Conduit artery endothelial-dependent function</measure>
    <time_frame>Day 10</time_frame>
    <description>Assessed by brachial artery flow mediated dilation (FMD)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Microvascular function</measure>
    <time_frame>Day 10</time_frame>
    <description>Assessed by Near Infrared Spectroscopy (NIRS)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood pressure reactivity</measure>
    <time_frame>Day 10</time_frame>
    <description>Assessed by the change in blood pressure during Handgrip Exercise and Cold Pressor test from baseline</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Cardiovascular Risk Factor</condition>
  <arm_group>
    <arm_group_label>High Salt and Melatonin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will consume sodium pills throughout the day achieving a total of 6900 mg sodium/day (4600 mg of sodium from pills and 2300 mg from diet) and will supplement with 10 mg (single dose) of melatonin at night.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High Salt and Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Subjects will consume sodium pills throughout the day achieving a total of 6900 mg sodium/day (4600 mg of sodium from pills and 2300 mg from diet) and will supplement with a lactose placebo (single dose) at night.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Melatonin</intervention_name>
    <description>Daily consumption of a high sodium diet and melatonin for 10 days</description>
    <arm_group_label>High Salt and Melatonin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>aily consumption of a high sodium diet and placebo for 10 days</description>
    <arm_group_label>High Salt and Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy

          -  normal blood pressure

        Exclusion Criteria:

          -  hypertension

          -  heart disease

          -  diabetes

          -  kidney disease

          -  renal impairment

          -  cancer

          -  obese (BMI â‰¥30)

          -  sleep disorder

          -  use of tobacco products

          -  pregnant or breastfeeding

          -  take any medications for the above conditions

          -  endurance trained athletes

          -  night shift worker

          -  melatonin or antioxidant consumption for the previous 3 months

          -  use of selective serotonin reuptake inhibitors
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shannon L Lennon, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Delaware</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Macarena Ramos Gonzalez, MS</last_name>
    <phone>(302)831-3954</phone>
    <email>macramos@udel.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Shannon L Lennon, PhD</last_name>
    <phone>3028312798</phone>
    <email>slennon@udel.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Delaware</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19711</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liza J Walker, BS</last_name>
      <phone>302-831-3181</phone>
      <email>lizaj@udel.edu</email>
    </contact>
    <contact_backup>
      <last_name>Shannon L Lennon, PhD</last_name>
      <phone>(302)831-2798</phone>
      <email>slennon@udel.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 19, 2020</study_first_submitted>
  <study_first_submitted_qc>March 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 27, 2020</study_first_posted>
  <last_update_submitted>March 25, 2020</last_update_submitted>
  <last_update_submitted_qc>March 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Vascular Health</keyword>
  <keyword>Melatonin</keyword>
  <keyword>Dietary Sodium</keyword>
  <keyword>Blood Pressure</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Melatonin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

